Dendrobium mixture regulates hepatic gluconeogenesis in diabetic rats via the phosphoinositide‑3‑kinase/protein kinase B signaling pathway

Lin,Xinjun; Shi,Hong; Cui,Yi; Wang,Xiaoning; Zhang,Jieping; Yu,Wenzhen; Wei,Min

doi:10.3892/etm.2018.6194

Dendrobium mixture regulates hepatic gluconeogenesis in diabetic rats via the phosphoinositide‑3‑kinase/protein kinase B signaling pathway

Authors:
- Xinjun Lin
- Hong Shi
- Yi Cui
- Xiaoning Wang
- Jieping Zhang
- Wenzhen Yu
- Min Wei
View Affiliations

Affiliations: Institute of Integrated Chinese and Western Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, P.R. China, Department of Ophthalmology, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, P.R. China
Published online on: May 18, 2018 https://doi.org/10.3892/etm.2018.6194
Pages: 204-212
Copyright: © Lin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to evaluate the impact of dendrobium mixture (DMix) on the gene and protein expression of insulin signaling pathway‑associated factors in the livers of diabetic rats. The molecular mechanisms by which DMix inhibits gluconeogenesis were also investigated. A total of 47 female Wistar rats were used in the present study. Of these, 11 rats were randomly selected as healthy controls and diabetes was induced in the remaining 36 rats by administering a high‑fat and high‑sugar diet for 6 weeks, followed by two intraperitoneal injections of streptozotocin. The 36 rats were screened for diabetes and then randomly divided into three groups: Model, metformin and DMix groups. Following 12 weeks of treatment, the fasting blood glucose (FBG), glycosylated serum protein (GSP), serum insulin, blood lipids [total cholesterol (Tch) and triglycerides (TG)], alanine transaminase (ALT) and aspartate transaminase (AST) were assessed. In addition, hematoxylin and eosin staining was used for histomorphological examination of the liver tissues. The mRNA expression of insulin receptor (InsR), forkhead box protein O1 (FoxO1), phosphoenolpyruvate carboxykinase (PEPCK) and glucose 6‑phosphatase (G6Pase) in the liver was measured with reverse transcription‑quantitative polymerase chain reaction and the protein expression of InsR, phosphoinositide‑3‑kinase (PI3K), phosphorylated (p)‑PI3K, protein kinase B (Akt), p‑Akt, FoxO1, PEPCK and G6Pase in the liver was measured by western blot analysis. The FBG, GSP, InsR, Tch, TG, ALT and AST levels were significantly lower in the DMix‑treated group compared with the model group (P<0.05). In addition, DMix treatment notably improved liver histopathology and significantly increased the gene and protein expression of InsR, PI3K and Akt (P<0.05). DMix treatment also significantly reduced the gene and protein expression of FoxO1, PEPCK and G6Pase (P<0.05). DMix effectively reduced FBG and blood lipids and significantly improved liver function and insulin resistance in diabetic rats, possibly by regulating the gene and protein expression of molecules associated with the PI3K/Akt signaling pathway.

View Figures

View References

1	Xu Y, Wang L, He J, Bi Y, Li M, Wang T, Wang L, Jiang Y, Dai M, Lu J, et al: Prevalence and control of diabetes in chinese adults. JAMA. 310:948–959. 2013. View Article : Google Scholar : PubMed/NCBI
2	Boj SF, van Es JH, Huch M, Li VS, José A, Hatzis P, Mokry M, Haegebarth A, van den Born M, Chambon P, et al: Diabetes risk gene and Wnt effector Tcf7l2/TCF4 controls hepatic response to perinatal and adult metabolic demand. Cell. 151:1595–1607. 2012. View Article : Google Scholar : PubMed/NCBI
3	Gao J, Duan C and Li LJ: The pathogenesis mechanisms of type 2 diabetes mellitus. Medical Recapitulate. 21:3935–3938. 2015.(In Chinese).
4	Steinbrunn T, Stühmer T, Sayehli C, Chatterjee M, Einsele H and Bargou RC: Combined targeting of MEK/MAPK and PI3K/Akt signalling in multiple myeloma. Br J Haematol. 159:430–440. 2012. View Article : Google Scholar : PubMed/NCBI
5	Bence KK: Hepatic PTP1B deficiency: The promise of a treatment for metabolic syndrome. J Clin Metab Diabetes. 1:27–33. 2010.PubMed/NCBI
6	Hojlund K: Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance. Dan Med J. 61:B48902014.PubMed/NCBI
7	Yang X and Su Dongming D: Effects of HRD1 expression in hepatic gluconeogenesis. Jiangsu Med J. 13:908–911. 2017.(In Chinese).
8	Enes P, Panserat S, Kaushik S and Oliva-Teles A: Nutritional regulation of hepatic glucose metabolism in fish. Fish Physiol Biochem. 35:519–539. 2009. View Article : Google Scholar : PubMed/NCBI
9	Staehr P, Hother-Nielsen O and Beck-Nielsen H: The role of the liver in type 2diabetes. Rev Endocr Metab Disord. 5:105–110. 2004. View Article : Google Scholar : PubMed/NCBI
10	Houde VP, Brule S, Festuccia WT, Blanchard PG, Bellmann K, Deshaies Y and Marette A: Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue. Diabetes. 59:1338–1348. 2010. View Article : Google Scholar : PubMed/NCBI
11	Gross DN, Wan M and Birnbaum MJ: The role of FoxO in the regulation of metabolism. Curr Diab Rep. 9:208–214. 2009. View Article : Google Scholar : PubMed/NCBI
12	Wang Q, Wang N, Dong M, Chen F, Li Z and Chen Y: GdC13 reduces Hyperglycaemia through Akt/FoxOl-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice. Clin Sci (Lond.). 127:91–100. 2014. View Article : Google Scholar : PubMed/NCBI
13	Tang WL, Wang YM, Du WM, Chen BY and Cheng NN: Analysis of adverse drug reaction of antidiabetic agents according to documents within forty-two years in China. Chin J New Drugs Clin Rem. 21:753–768. 2002.(In Chinese).
14	Zhu Y, Song C, Huo H, et al: Research of traditional chinese medicine in treating type diabetes and insulin resistance. World Chin Med. 10:135–137. 2015.(In Chinese).
15	Ke Z, Hou X and Jia X: Application idea and method discussion of Chinese materia medica with hypoglycemic effect based on active ingredients. Chin Traditional Herbal Drugs. 47:1797–1805. 2016.(In Chinese).
16	Shi H, Zhang X, Cui Yi, et al: Clinical sequential treatment and experimental studies of DC for diabetes mellitus. Clinical J Chin Med. 5:1–3. 2013.(In Chinese).
17	Xin J, Wang Q, Chen L, et al: Clinical sequential treatment and experimental studies on the effect of dendrobium powder on insulin resistance in type 2 diabetes mellitus. China Modern Doctor. 48:58–59. 2010.(In Chinese).
18	Liu Y and He R: Fasting induces a high level of 3-nitrotyrosine in the brain of rats. Neurosci Lett. 472:204–209. 2010. View Article : Google Scholar : PubMed/NCBI
19	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
20	Whiting DR, Guariguata L, Weil C and Shaw J: IDF diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 94:311–321. 2011. View Article : Google Scholar : PubMed/NCBI
21	Wang J, Shen X, Fu C, et al: Type2 rat diabetic models induced by high-fat feeding combined with Streptozocin. Jilin Med J. 32:629–633. 2011.(In Chinese).
22	Matteucci E and Giampietro O: Proposal open for discussion: Defining agreed diagnostic Procedures in experimental diabetes research. J Ethnopharmacol. 115:163–172. 2008. View Article : Google Scholar : PubMed/NCBI
23	Lin X, Wang Q, Xin J, et al: The study of establishing a highly stable and successful diabetic rat model. Chin J Gerontology. 5:2051–2054. 2013.(In Chinese).
24	Bai X, Huang Y and Xu Y: The knowledge of modern physicians on diabetes pathogenesis of tcm. Guangming J Chin Med. 30:206–209. 2015.(In Chinese).
25	Xu Q, Liu Y, Cong YB, Zheng YY, Zhang JP and Shi H: Gene expression and microarray investigation of dendrobium mixture as progressive therapy for the treatment of type 2 diabetes mellitus. Tropical J Pharmaceutical Res. 12:195–201. 2013.
26	Patel DK, Kumar R, Laloo D and Hemalatha S: Diabetes mellitus: An overview on its pharmacological aspects and reported medicinal plants having antidiabetic activity. Asian Pac J Trop Biomed. 2:411–420. 2012. View Article : Google Scholar : PubMed/NCBI
27	Li X, Li S, Huang T and Bai H: Effect of aerobic exercise and diet intervention on male college students with variants of FTO gene. J Shanghai University Sport. 38:95–99. 2014.(In Chinese).
28	Zhang Y: Clinical study on Ziyin Yiqi pills in treatment of diabetic nephropathy. China J Chin Med. 20:1593–1594. 2015.
29	Yu WZ, Chen LJ and Shi H: Effect of the method of nourishing-‘yin’, Tonifying-‘qi’ and activating-blood on caspase-3 mrna expression in pancreas of aged diabetic rats. Lishizhen Medicine and Materia Medica Res. 23:2040–2042. 2012.(In Chinese).
30	Stumvoll M, Nurjhan N, Perriello G, Dailey G and Gerich JE: Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med. 333:550–554. 1995. View Article : Google Scholar : PubMed/NCBI
31	Wulffelé MG, Kooy A, de Zeeuw D, Stehouwer CD and Gansevoort RT: The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: A systematic review. J Intern Med. 256:1–14. 2004. View Article : Google Scholar : PubMed/NCBI
32	Nakahara T, Hyogo H, Yoneda M, Sumida Y, Eguchi Y, Fujii H, Ono M, Kawaguchi T, Imajo K, Aikata H, et al: Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients. J Gastroenterol. 49:1477–1484. 2014. View Article : Google Scholar : PubMed/NCBI
33	Zhou YJ, Li YY, Nie YQ, Huang CM and Cao CY: Natural course of nonalcoholic fatty liver disease in southern China: A prospective cohort study. J Dig Dis. 13:153–160. 2012. View Article : Google Scholar : PubMed/NCBI
34	Bhaha N, Younes R and Bugianesi E: Epidemiology and natural history of patients with NAFLD. Curr Pharm Des. 19:5169–5176. 2013. View Article : Google Scholar : PubMed/NCBI
35	Vozarova B, Stefan N, Lindsay RS, Saremi A, Pratley RE, Bogardus C and Tataranni PA: High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes. 51:1889–1895. 2002. View Article : Google Scholar : PubMed/NCBI
36	Nolan CJ, Ruderman NB, Kahn SE, Pedersen O and Prentki M: Response to Comments on Nolan: Insulin resistance as a physiological defense against metabolic stress: Implications for the management of subsets of type 2 diabetes. Diabetes. 64:673–686. 2015. View Article : Google Scholar : PubMed/NCBI
37	Gray SL, Donald C, Jetha A, Covey SD and Kieffer TJ: Hyperinsulinemia precedes insulin resistance in mice lacking pancreatic beta-cell leptin signaling. Endocrinology. 151:4178–1486. 2010. View Article : Google Scholar : PubMed/NCBI
38	Wang Y, Li B, Zhang W, Liu Y, Xue P, Ma J and Li Y: Impaired PI3K Akt expression in liver and skeletal muscle of ovariectomized rats. Endocrine. 44:659–665. 2013. View Article : Google Scholar : PubMed/NCBI
39	Wang YM, Lin XF, Shi CM, Lu L, Qin ZY, Zhu GZ, Cao XG, Ji CB, Qiu J and Guo XR: α-Lipoic acid protects 3T3-L1, adipocytes from NYGGF4 (PID1) overexpression-induced insulin resistance through increasing phosphorylation of IRS-1 and Akt. J Bioenerg Biomembr. 44:357–363. 2012. View Article : Google Scholar : PubMed/NCBI
40	Han K, Xu X, Chen G, Zeng Y, Zhu J, Du X, Zhang Z, Cao B, Liu Z and Mao X: Identification of a promising PI3K inhibitor for the treatment of multiple myeloma through the structural optimization. J Hematol Oncol. 7:92014. View Article : Google Scholar : PubMed/NCBI
41	Tomas NM, Masur K, Piecha JC, Niggemann B and Zänker KS: Akt and phospholipase Cγ are involved in the regulation of growth and migration of MDA-MB-468 breast cancer and SW480 colon cancer cells when cultured with diabetogenic levels of glucose and insulin. BMC Res Notes. 5:2142012. View Article : Google Scholar : PubMed/NCBI
42	Ropelle ER, Pauli JR, Prada P, Cintra DE, Rocha GZ, Moraes JC, Frederico MJ, da Luz G, Pinho RA, Carvalheira JB, et al: Inhibition of hypothalamic Foxo1 expression reduced food intake in diet-induced obesity rats. J Physiol. 587:2341–2351. 2009. View Article : Google Scholar : PubMed/NCBI
43	Fabbrini E, Sullivan S and Klein S: Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications. Hepatology. 51:679–689. 2010. View Article : Google Scholar : PubMed/NCBI
44	Gómez-Valadés AG, Vidal-Alabró A, Molas M, Boada J, Bermúdez J, Bartrons R and Perales JC: Overcoming diabetes-induced hyperglycemia through inhibition of hepatic phosphoenolpyruvate carboxykinase (GTP) with RNAi. Mol Ther. 13:401–410. 2006. View Article : Google Scholar : PubMed/NCBI
45	Kim YK, Lee GS, Jung EM, Hyun SH, Hwang WS and Jeung EB: Generation of fibroblasts overexpressing liver-specific PEPCK in a miniature pig model of human type 2 diabetes mellitus. Mol Med Rep. 6:45–50. 2012.PubMed/NCBI
46	Hutton JC and O'Brien RM: Glucose-6-phosphatase catalytic subunit gene family. J Biol Chem. 284:29241–29245. 2009. View Article : Google Scholar : PubMed/NCBI
47	Costa-Júnior JM, Ferreira SM, Protzek AO, Santos GJ, Cappelli AP, Silveira LR, Zoppi C, de Oliveira CA, Boschero AC, Carneiro EM and Rezende LF: Endurance training inhibits insulin clearance and IDE expression in Swiss mice. PLoS One. 10:e01188092015. View Article : Google Scholar : PubMed/NCBI